Is it worth me buying more AstraZeneca shares at just over £13?
Fool UKarrow_outwardIs it worth me buying more AstraZeneca shares at just over £13?
Yahoo.coarrow_outwardBusiness news live: Reaction to FTSE 100 firms including Greggs and AstraZeneca’s latest profits - The Independent
The Independentarrow_outwardAstraZeneca (LSE:AZN) Commits US$50 Billion For US Expansion By 2030 - simplywall.st
Simplywall.starrow_outwardHere's why AstraZeneca Pharma share price is down over 2% today - Business Standard
Business Standardarrow_outwardAstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - Braintree & Witham Times
Braintree & Witham Timesarrow_outwardAstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - London Evening Standard
London Evening Standardarrow_outwardAstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - Maldon & Burnham Standard
Maldon & Burnham Standardarrow_outwardAstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - Stourbridge News
Stourbridge Newsarrow_outwardAstraZeneca’s stock market exit would be devastating blow, warns ex-chancellor - Halstead Gazette
Halstead Gazettearrow_outwardLondon Share Listings Hit 30-Year Low Amid AstraZeneca Exit Fears - AskTraders.com
AskTraders.comarrow_outwardAstraZeneca has eyes on Summit's billion-dollar cancer drug - medwatch.com
Medwatch.comarrow_outwardLosing AstraZeneca would be more than a bitter pill for the City – it could be fatal - City AM
City AMarrow_outwardAstraZeneca exit is a frightening prospect for the City and the government - Sky News
Sky Newsarrow_outwardIf AstraZeneca quits the London Stock Exchange, it will be a disaster - The Spectator
The Spectatorarrow_outwardAstraZeneca boss mulls US listing in fresh blow for City - businessplus.ie
Businessplus.iearrow_outwardAstraZeneca CEO mulls moving listing to the US – reports - Investment Week
Investment Weekarrow_outwardUK markets digest another black hole in the UK finances, and Astra Zeneca gets NYSE FOMO - FXStreet
FXStreetarrow_outwardPharmalittle: We're reading about Spain probing Novo weight loss ads, AstraZeneca stock listing, and more - statnews.com
Statnews.comarrow_outwardAstraZeneca shares pop on news CEO wants to move base to US - Proactive financial news
Proactive financial newsarrow_outwardAstraZeneca boss ‘wants to shift stock market listing to US’ - The Guardian
The Guardianarrow_outwardAstraZeneca CEO wants to move listing to the US - The Times
The Timesarrow_outwardWhy AstraZeneca Stock Topped the Market on Tuesday - The Motley Fool
The Motley Foolarrow_outwardAstraZeneca Announces Updated Share Capital and Voting Rights - TipRanks
TipRanksarrow_outwardAstraZeneca considers moving listing to US, the Times reports - Reuters
Reutersarrow_outwardApproval for AstraZeneca’s Datroway drug a ’minor positive’ for shares: JPMorgan - Investing.com UK
Investing.com UKarrow_outwardWhy Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Yahoo Financearrow_outwardAstraZeneca’s growth prospects are as attractive as ever. Keep buying - The Telegraph
The Telegrapharrow_outwardAstraZeneca’s share price is down 20% from September, so is it time for me to buy? - MSN
MSNarrow_outwardAstraZeneca shares fall 4% after Q1 revenue miss - Proactive Investors
Proactive Investorsarrow_outwardeyeQ: why AstraZeneca shares now look interesting - Interactive Investor
Interactive Investorarrow_outward3 stocks to watch in 2025: Alphabet(GOOG), AstraZeneca(AZN), Trade Desk(TTD) - Markets.com
Markets.comarrow_outwardAstraZeneca stock touches 52-week low at $61.76 - Investing.com
Investing.comarrow_outwardAstraZeneca’s shares rise as it addresses China investigation - Pharmaceutical Technology
Pharmaceutical Technologyarrow_outwardAstraZeneca: strong final quarter drives full year revenue beat | HL - Hargreaves Lansdown
Hargreaves Lansdownarrow_outwardAstraZeneca Stock Rally Will be Tested by Answers on China Probe - Bloomberg
Bloombergarrow_outwardAstraZeneca goes cheap – should you buy? - MoneyWeek
MoneyWeekarrow_outwardAstraZeneca shares fall as China probe intensifies - Financial Times
Financial Timesarrow_outward
Astrazeneca Share Price close
- 2025-07-29 15:00 event
- 38 sourceslanguage
- 100+ ads_click
- 3 weeks ago schedule